AlTi Global Inc. Reduces Stake in Privia Health Group, Inc. $PRVA

Key Points

• AlTi Global Inc. has reduced its stake in Privia Health Group by 30.7%, selling 50,000 shares, and now owns approximately 0.09% of the company worth $2.528 million.
• Privia Health Group recently missed earnings expectations, reporting $0.02 EPS against a consensus estimate of $0.05 EPS, despite achieving a revenue of $521.15 million.
• Analysts have mixed views on Privia Health Group, with target prices ranging from $24.00 to $36.00 and an average rating of "Moderate Buy".

AlTi Global Inc. cut its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 30.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 112,615 shares of the company's stock after selling 50,000 shares during the period. AlTi Global Inc. owned approximately 0.09% of Privia Health Group worth $2,528,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. US Bancorp DE raised its stake in Privia Health Group by 2.4% during the 1st quarter. US Bancorp DE now owns 18,487 shares of the company's stock valued at $415,000 after acquiring an additional 429 shares during the last quarter. Park Avenue Securities LLC raised its stake in Privia Health Group by 3.6% during the 1st quarter. Park Avenue Securities LLC now owns 15,229 shares of the company's stock valued at $342,000 after acquiring an additional 532 shares during the last quarter. CWM LLC raised its stake in Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after acquiring an additional 604 shares during the last quarter. Financial Management Professionals Inc. raised its stake in Privia Health Group by 28.7% during the 1st quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company's stock valued at $76,000 after acquiring an additional 754 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after acquiring an additional 1,521 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on the company. Piper Sandler reduced their price objective on Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a research note on Monday, August 11th. Citigroup reissued an "outperform" rating on shares of Privia Health Group in a research note on Friday, August 29th. JPMorgan Chase & Co. increased their target price on Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 28th. JMP Securities increased their target price on Privia Health Group from $29.00 to $30.00 and gave the stock a "market outperform" rating in a research note on Friday, August 29th. Finally, Barclays increased their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a research note on Tuesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $28.58.

Privia Health Group Stock Down 0.4%

NASDAQ PRVA traded down $0.10 during mid-day trading on Tuesday, hitting $23.49. The stock had a trading volume of 142,357 shares, compared to its average volume of 837,396. Privia Health Group, Inc. has a 52-week low of $16.47 and a 52-week high of $26.09. The company has a market cap of $2.88 billion, a price-to-earnings ratio of 213.65, a P/E/G ratio of 3.37 and a beta of 0.82. The company has a 50 day simple moving average of $21.05 and a 200 day simple moving average of $22.56.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The firm had revenue of $521.15 million during the quarter, compared to analysts' expectations of $466.97 million. During the same period in the previous year, the business earned $0.19 earnings per share. The business's revenue for the quarter was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS. As a group, equities analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.